Literature DB >> 22516527

Association between retinopathy and cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC] Study).

Juan E Grunwald1, Gui-Shuang Ying, Maureen Maguire, Maxwell Pistilli, Ebenezer Daniel, Judith Alexander, Revell Whittock-Martin, Candace Parker, Emile Mohler, Joan Chia-Mei Lo, Raymond Townsend, Crystal Ann Gadegbeku, James Phillip Lash, Jeffrey Craig Fink, Mahboob Rahman, Harold Feldman, John Walter Kusek, Dawei Xie, Martha Coleman, Martin Gerard Keane.   

Abstract

Patients with chronic kidney disease experience co-morbid illnesses, including cardiovascular disease (CVD) and retinopathy. The purpose of the present study was to assess the association between retinopathy and self-reported CVD in a subgroup of the participants in the Chronic Renal Insufficiency Cohort study. For this observational, ancillary investigation, 2,605 Chronic Renal Insufficiency Cohort participants were invited to participate in the present study, and nonmydriatic fundus photographs in both eyes were obtained for 1,936 subjects. The photographs were reviewed in a masked fashion at a central photograph reading center. The presence and severity of retinopathy (diabetic, hypertensive, or other) and vessel diameter caliber were assessed using standard protocols by trained graders who were masked to the information about the study participants. A history of self-reported CVD was obtained using a medical history questionnaire. Kidney function measurements and traditional and nontraditional risk factors for CVD were obtained from the Chronic Renal Insufficiency Cohort study. A greater severity of retinopathy was associated with a greater prevalence of any CVD, and this association persisted after adjustment for the traditional risk factors for CVD. The presence of vascular abnormalities usually associated with hypertension was also associated with increased prevalence of CVD. We found a direct relation between CVD prevalence and mean venular caliber. In conclusion, the presence of retinopathy was associated with CVD, suggesting that retinovascular pathology might indicate macrovascular disease, even after adjustment for renal dysfunction and traditional CVD risk factors. This would make the assessment of retinal morphology a valuable tool in CKD studies of CVD outcomes.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22516527      PMCID: PMC3383900          DOI: 10.1016/j.amjcard.2012.03.014

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  29 in total

1.  The relationship between retinal arteriolar and venular calibers is genetically mediated, and each is associated with risk of cardiovascular disease.

Authors:  Samantha J Fahy; Cong Sun; Gu Zhu; Paul R Healey; Tim D Spector; Nicolas G Martin; Paul Mitchell; Tien Y Wong; David A Mackey; Christopher J Hammond; Toby Andrew
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-23       Impact factor: 4.799

2.  Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study.

Authors:  L D Hubbard; R J Brothers; W N King; L X Clegg; R Klein; L S Cooper; A R Sharrett; M D Davis; J Cai
Journal:  Ophthalmology       Date:  1999-12       Impact factor: 12.079

Review 3.  Hemodynamic factors in the genesis of diabetic microangiopathy.

Authors:  H H Parving; G C Viberti; H Keen; J S Christiansen; N A Lassen
Journal:  Metabolism       Date:  1983-09       Impact factor: 8.694

4.  Experimental hypertensive retinopathy in the monkey.

Authors:  N Ashton; S Peltier; A Garner
Journal:  Trans Ophthalmol Soc U K       Date:  1969

5.  Are retinal arteriolar abnormalities related to atherosclerosis?: The Atherosclerosis Risk in Communities Study.

Authors:  R Klein; A R Sharrett; B E Klein; L E Chambless; L S Cooper; L D Hubbard; G Evans
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-06       Impact factor: 8.311

6.  Bidirectional association of retinal vessel diameters and estimated GFR decline: the Beaver Dam CKD Study.

Authors:  Charumathi Sabanayagam; Anoop Shankar; Barbara E K Klein; Kristine E Lee; Paul Muntner; F Javier Nieto; Michael Y Tsai; Karen J Cruickshanks; Carla R Schubert; Peter C Brazy; Josef Coresh; Ronald Klein
Journal:  Am J Kidney Dis       Date:  2011-05       Impact factor: 8.860

7.  Pathogenesis of hypertensive retinopathy. An experimental study in the monkey.

Authors:  A Garner; N Ashton; R Tripathi; E M Kohner; C J Bulpitt; C T Dollery
Journal:  Br J Ophthalmol       Date:  1975-01       Impact factor: 4.638

8.  Pathophysiology of hypertensive retinopathy.

Authors:  M O Tso; L M Jampol
Journal:  Ophthalmology       Date:  1982-10       Impact factor: 12.079

9.  The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods.

Authors:  Harold I Feldman; Lawrence J Appel; Glenn M Chertow; Denise Cifelli; Borut Cizman; John Daugirdas; Jeffrey C Fink; Eunice D Franklin-Becker; Alan S Go; L Lee Hamm; Jiang He; Tom Hostetter; Chi-Yuan Hsu; Kenneth Jamerson; Marshall Joffe; John W Kusek; J Richard Landis; James P Lash; Edgar R Miller; Emile R Mohler; Paul Muntner; Akinlolu O Ojo; Mahboob Rahman; Raymond R Townsend; Jackson T Wright
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

10.  Retinal microvascular abnormalities and blood pressure in older people: the Cardiovascular Health Study.

Authors:  T Y Wong; L D Hubbard; R Klein; E K Marino; R Kronmal; A R Sharrett; D S Siscovick; G Burke; J M Tielsch
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

View more
  20 in total

Review 1.  The role of noninvasive cardiovascular testing, applied clinical nutrition and nutritional supplements in the prevention and treatment of coronary heart disease.

Authors:  Mark Houston
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-01-10

2.  The degree of retinopathy is equally predictive for renal and macrovascular outcomes in the ACCORD Trial.

Authors:  Amy K Mottl; Nicholas Pajewski; Vivian Fonseca; Faramarz Ismail-Beigi; Emily Chew; Walter T Ambrosius; Craig Greven; Ulrich Schubart; John Buse
Journal:  J Diabetes Complications       Date:  2014-07-12       Impact factor: 2.852

3.  Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.

Authors:  Rupal Mehta; Gui Shuang Ying; Samuel Houston; Tamara Isakova; Lisa Nessel; Akinlolu Ojo; Alan Go; Jim Lash; John Kusek; Juan Grunwald; Myles Wolf
Journal:  Nephrol Dial Transplant       Date:  2015-04-24       Impact factor: 5.992

4.  Retinopathy and CKD as predictors of all-cause and cardiovascular mortality: National Health and Nutrition Examination Survey (NHANES) 1988-1994.

Authors:  Ana C Ricardo; Juan E Grunwald; Sharmila Parvathaneni; Sean Goodin; Alice Ching; James P Lash
Journal:  Am J Kidney Dis       Date:  2014-03-19       Impact factor: 8.860

5.  Retinopathy and cognitive impairment in adults with CKD.

Authors:  Kristine Yaffe; Lynn Ackerson; Tina D Hoang; Alan S Go; Maureen G Maguire; Gui-Shuang Ying; Ebenezer Daniel; Lydia A Bazzano; Martha Coleman; Debbie L Cohen; John W Kusek; Akinlolu Ojo; Stephen Seliger; Dawei Xie; Juan E Grunwald
Journal:  Am J Kidney Dis       Date:  2012-12-01       Impact factor: 8.860

6.  Mortality in Older Persons with Retinopathy and Concomitant Health Conditions: The Age, Gene/Environment Susceptibility-Reykjavik Study.

Authors:  Diana E Fisher; Fridbert Jonasson; Ronald Klein; Palmi V Jonsson; Gudny Eiriksdottir; Lenore J Launer; Vilmundur Gudnason; Mary Frances Cotch
Journal:  Ophthalmology       Date:  2016-04-07       Impact factor: 12.079

7.  Retinopathy and the risk of cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort study).

Authors:  Juan E Grunwald; Maxwell Pistilli; Gui-Shuang Ying; Maureen Maguire; Ebenezer Daniel; Revell Whittock-Martin; Candace Parker-Ostroff; Emile Mohler; Joan C Lo; Raymond R Townsend; Crystal Ann Gadegbeku; James Phillip Lash; Jeffrey Craig Fink; Mahboob Rahman; Harold Feldman; John W Kusek; Dawei Xie
Journal:  Am J Cardiol       Date:  2015-08-31       Impact factor: 2.778

Review 8.  Biomarkers in Diabetic Retinopathy.

Authors:  Alicia J Jenkins; Mugdha V Joglekar; Anandwardhan A Hardikar; Anthony C Keech; David N O'Neal; Andrzej S Januszewski
Journal:  Rev Diabet Stud       Date:  2015-08-10

9.  Progression of retinopathy and incidence of cardiovascular disease: findings from the Chronic Renal Insufficiency Cohort Study.

Authors:  Juan E Grunwald; Maxwell Pistilli; Gui-Shuang Ying; Maureen G Maguire; Ebenezer Daniel; Revell Whittock-Martin; Candace Parker-Ostroff; Douglas Jacoby; Alan S Go; Raymond R Townsend; Crystal Ann Gadegbeku; James P Lash; Jeffrey Craig Fink; Mahboob Rahman; Harold Feldman; John W Kusek; Dawei Xie
Journal:  Br J Ophthalmol       Date:  2020-06-05       Impact factor: 4.638

10.  Exploring the Pharmacological Mechanism of Liuwei Dihuang Decoction for Diabetic Retinopathy: A Systematic Biological Strategy-Based Research.

Authors:  Mengxia Yuan; Qi He; Zhiyong Long; Xiaofei Zhu; Wang Xiang; Yonghe Wu; Shibin Lin
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-02       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.